Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc (RANI) Unusual Options Activity Today
RANI options volume power reached 1x on the previous trading day. The highest reading was on the $1.5 PUT expiring 2026-10-16.
Read more
Checking RANI unusual options activity helps you spot when traders are making outsized bets on Rani Therapeutics Holdings Inc before the broader market catches on. Rani Therapeutics Holdings Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor RANI unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching RANI unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking RANI unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and RANI unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes.
The company was incorporated in 2012 and is headquartered in San Jose, California.
Catalysts rarely arrive without a footprint, and RANI unusual options activity is often where that footprint shows up first. Our scanner tracks Rani Therapeutics Holdings Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at RANI unusual options volume on the call side or chasing put sweeps, Rani Therapeutics Holdings Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 1.50 | — | 0.05 | 0.05 | 283% | 23 | 534 | 4.31% |
| 0.50 | — | 0.50 | 0.50 | 675% | 0 | 91 | 0.00% |
| 1.00 | — | 0.10 | 0.10 | 247% | 0 | 1,434 | 0.00% |
| 2.00 | — | 0.10 | 0.10 | 442% | 0 | 21 | 0.00% |
| 2.50 | — | 0.45 | 0.45 | 1,000% | 0 | 216 | 0.00% |
| 0.50 | — | 0.05 | 0.05 | 277% | 0 | 130 | 0.00% |
| 1.00 | — | 0.75 | 0.75 | 977% | 0 | 0 | — |
| 1.50 | 0.35 | 1.10 | 0.73 | 176% | 0 | 3 | 0.00% |
| 2.00 | 0.85 | 1.75 | 1.30 | 415% | 0 | 30 | 0.00% |
| 2.50 | 1.35 | 2.10 | 1.73 | 282% | 0 | 0 | — |
As of September 28, 2026
Spot unusual options activity before it moves
Track RANI options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→